Navigation Links
Alma Lasers Answers Lumenis Complaint
Date:10/15/2007

BUFFALO GROVE, Ill., Oct. 15 /PRNewswire/ -- Alma Lasers Ltd., a global leader in the development and commercialization of innovative aesthetic laser, light-based, and radiofrequency systems, filed a response last week denying all Lumenis' patent infringement claims. Alma Lasers will vigorously defend its position.

"Alma Lasers continues to build momentum in the marketplace due to our innovation, value and high customer service," stated Howard Kelly, CEO of Alma Lasers. "It is unfortunate that certain competitors resort to litigation to compensate for their failings in the marketplace."

Previously, Lumenis tried to enforce two of the same patents it is now asserting against Alma in a lawsuit against another company and failed. With respect to those two patents, a federal district judge denied Lumenis' Motion for Preliminary Injunction, and questioned the validity of a Lumenis asserted claim in a published opinion. Lumenis ultimately settled that case before trial.

Alma Lasers continues to stand behind all of its products and their warranties. Our customers and prospective customers can be assured that this dispute will not impact their use of any Alma product.

About Alma Lasers Ltd.

Alma Lasers Ltd. is a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for aesthetic and medical applications. Since 1980, the founders of Alma Lasers have been at the forefront of innovative laser and light-based medical technology. Their technical expertise and in-depth understanding of practitioners' needs led to the development of Alma Lasers' multi-technology/multi-application systems. Alma Lasers' mission is to provide modular, cost-effective and high performance designs that enable medical practitioners to confidently offer safe, effective and profitable aesthetic treatments to their patients. More information about Alma Lasers can be found at http://www.almalasers.com. Alma Lasers. Wellbeing Through Technology.

Contact:

William Bruckner

Vice President, Global Marketing

Tel. 224.377.2010

billb@almalasers.com

Shai Halivni

Vice President, General Counsel

Tel: 224.377.2008

shaih@almalasers.com


'/>"/>
SOURCE Alma Lasers, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Better skin with lasers
2. Lasers for Acne
3. Nanocomposite Labeled Cancer Cells Targeted and Destroyed by Using Lasers
4. Dental Lasers can Help Eliminate Bacteria in Root Canals
5. Answers For OCD soon
6. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
7. SMS Help-line to Provide Answers for HIV/AIDS Queries
8. Yale Cancer Center Answers: A New Weekly Radio Progam on WNPR
9. Toxicology Test Will Give Me Answers-Benoits Dad
10. Gastrointestinal Complaint to be dealt Psychologically
11. Complaints Of Memory Loss Could Be Signs Of Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... Clara, CA (PRWEB) , ... April 28, 2017 ... ... is pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep ... user experience, since it streamlines the reporting process and provides a familiar interface ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: